Overview

Rituximab in the Treatment of Scleritis and Non-Infectious Orbital Inflammation

Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and tolerability of Rituximab in refractory scleritis and non-infectious orbital inflammation.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Oregon Health and Science University
Collaborator:
Genentech, Inc.
Treatments:
Rituximab